Ignite Creation Date:
2024-05-05 @ 11:37 PM
Last Modification Date:
2024-10-26 @ 10:37 AM
Study NCT ID:
NCT01378637
Status:
UNKNOWN
Last Update Posted:
2016-12-08
First Post:
2011-02-18
Brief Title:
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Sponsor:
AMES Technology
Organization:
AMES Technology
Study Overview
Official Title:
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Status:
UNKNOWN
Status Verified Date:
2016-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AMES
Brief Summary:
The purpose of this protocol is to determine if individuals who had a stroke more than one year before entering the study and whose ankles remain substantially impaired are able to sense and move the affected leg better after 9-13 weeks of treatment with a robotic therapy device AMES
Detailed Description:
Our research objective is to develop procedures to rehabilitate those stroke patients who through conventional therapies are not brought to a level of maximal recovery The aims of the proposed project are to obtain a set of data from a total of 20 chronic stroke subjects all with severe lower extremity disability between the ages of 18-85 using a robotic therapeutic device placed in a rehabilitation clinic This data will allow us to quantify the extent to which a combination of robotic-assisted exercise and tendon vibration from the AMES beta device induces secondary recovery from the effects of stroke on the lower extremity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R44NS060192-03 | NIH | None | httpsreporternihgovquickSearchR44NS060192-03 |